Home » All » Stock Forecast » CG Oncology Inc. Common stock Forecast

CG Oncology Inc. Common stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC
▲ +2.04%Market Cap $6.07B · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

TimeframePredicted PricePastHistoricalInsight
Tomorrow$71.14 -0.97%Yesterday$72.13 +0.41%Tomorrow's CG Oncology Inc. Common stock (CGON) setup is anchored to $71.84 and targets $71.14 (-0.97%). The near-term read is downside; watch $74.00 / $69.68 because daily realized volatility is about 5.01%.
Tomorrow's CG Oncology Inc. Common stock (CGON) setup is anchored to $71.84 and targets $71.14 (-0.97%). The near-term read is downside; watch $74.00 / $69.68 because daily realized volatility is about 5.01%.
Week$69.67 -3.02%Last Week$72.75 +1.27%The 7-day CG Oncology Inc. Common stock model moves from $72.75 to $69.67 (-3.02%). It gives downside momentum context for this stock, so breaks around $74.00 / $69.68 matter more than a single tick.
The 7-day CG Oncology Inc. Common stock model moves from $72.75 to $69.67 (-3.02%). It gives downside momentum context for this stock, so breaks around $74.00 / $69.68 matter more than a single tick.
Month$67.21 -6.44%Last Month$73.78 +2.71%The 1-month CG Oncology Inc. Common stock target is $67.21 (-6.44%), compared with the live reference near $71.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month CG Oncology Inc. Common stock target is $67.21 (-6.44%), compared with the live reference near $71.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$63.53 -11.57%Last Year$75.33 +4.86%The 1-year CG Oncology Inc. Common stock scenario points to $63.53 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year CG Oncology Inc. Common stock scenario points to $63.53 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$54.91 -23.57%5 Years Ago$78.95 +9.90%The 5-year CG Oncology Inc. Common stock view is $54.91 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year CG Oncology Inc. Common stock view is $54.91 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Tomorrow$71.14 -0.97%
Yesterday$72.13 +0.41%
Tomorrow's CG Oncology Inc. Common stock (CGON) setup is anchored to $71.84 and targets $71.14 (-0.97%). The near-term read is downside; watch $74.00 / $69.68 because daily realized volatility is about 5.01%.
Week$69.67 -3.02%
Last Week$72.75 +1.27%
The 7-day CG Oncology Inc. Common stock model moves from $72.75 to $69.67 (-3.02%). It gives downside momentum context for this stock, so breaks around $74.00 / $69.68 matter more than a single tick.
Month$67.21 -6.44%
Last Month$73.78 +2.71%
The 1-month CG Oncology Inc. Common stock target is $67.21 (-6.44%), compared with the live reference near $71.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$63.53 -11.57%
Last Year$75.33 +4.86%
The 1-year CG Oncology Inc. Common stock scenario points to $63.53 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$54.91 -23.57%
5 Years Ago$78.95 +9.90%
The 5-year CG Oncology Inc. Common stock view is $54.91 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish
$74.05$72.60$71.16$69.71$68.271W AgoNow7D F

Technical Analysis

SellNeutralBuy
Neutral
1
Bullish
3
Neutral
1
Bearish

Key Indicators

IndicatorValueSignal
Price$71.84 Mid
Daily Change+2.04% Above
Volatility Cap20.0% Mid
Confidence61% Below
Data Sourcenasdaq-screener Mid

Historical Data

Current$71.84
Daily Change+2.04%
Market Cap$6.07B
Sourcenasdaq-screener
Current$71.84Daily Change+2.04%
Market Cap$6.07BSourcenasdaq-screener

Support & Resistance Levels

$69.68Support 1
$71.84Current
$74.00Resistance 1
i
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context
Current$71.84Live reference price
Used as the anchor for generated forecast calculations.
Next Month$67.21Model projection-6.44%
Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed
61%
Directional
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.
Short term
61%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in CGON today
Bullish Scenario
$75.43
+5.00% from current
Target Price$75.43
ScenarioUpside momentum
Probability53%
Base Scenario
$67.21
-6.44%
Target Price$67.21
ScenarioCapped drift
Probability61%
Bearish Scenario
$68.25
-5.00% from current
Target Price$68.25
ScenarioVolatility drawdown
Probability39%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bearish · 36/100
24H drift-0.97%
7D drift-3.02%
30D drift-6.44%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-Off Caution · 29/100
1M outlook-6.44%
1Y outlook-11.57%
5Y outlook-23.57%

Frequently Asked Questions

Q What is the CG Oncology Inc. Common stock (CGON) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), CG Oncology Inc. Common stock is projected near $71.14 versus the current reference around $71.84. That implies a modeled move of -0.97% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for CGON?
The weekly CG Oncology Inc. Common stock model points to $69.67, which maps to an expected drift of -3.02% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the CG Oncology Inc. Common stock 1-month and 1-year targets?
The CG Oncology Inc. Common stock 1-month target is $67.21 (-6.44%), while the 1-year target is $63.53 (-11.57%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the CG Oncology Inc. Common stock 5-year scenario differ from short-term rows?
The CG Oncology Inc. Common stock long-horizon scenario sits near $54.91 with a modeled change of -23.57%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are CGON support and resistance zones right now?
For CG Oncology Inc. Common stock, nearest resistance is around $69.68, while nearest support is around $74.00. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the CG Oncology Inc. Common stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.
CG Oncology Inc. Common stock Forecast 2026 – Tomorrow, Week & Month